Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Kara Schenk MD

Kara M. Schenk MD

Adjunct Instructor of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland; Oncologist, Bozeman Health Cancer Center, Bozeman, Montana

A member of the Hopkins Melanoma Program and the Bozeman Health Deaconess Cancer Center, Dr. Kara M. Schenk has a special research interest in expanding the use of immunotherapy to high-risk or orphan patient groups with advanced skin cancers.

Disclosures

Dr. Schenk has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
  2. Nivolumab/Tacrolimus/Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers

Most Read This Week

Recently Updated